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Abstract
The goal of this study was to investigate whether cold plasma generated by dielectric barrier 
discharge (DBD) modifies extracellular matrices (ECM) to influence chondrogenesis and 
endochondral ossification. Replacement of cartilage by bone during endochondral ossification is 
essential in fetal skeletal development, bone growth and fracture healing. Regulation of this 
process by the ECM occurs through matrix remodelling, involving a variety of cell attachment 
molecules and growth factors, which influence cell morphology and protein expression. The 
commercially available ECM, Matrigel, was treated with microsecond or nanosecond pulsed (µsp 
or nsp, respectively) DBD frequencies conditions at the equivalent frequencies (1 kHz) or power 
(~1 W). Recombinant human bone morphogenetic protein-2 was added and the mixture 
subcutaneously injected into mice to simulate ectopic endochondral ossification. Two weeks later, 
the masses were extracted and analysed by microcomputed tomography. A significant increase in 
bone formation was observed in Matrigel treated with µsp DBD compared with control, while a 
significant decrease in bone formation was observed for both nsp treatments. Histological and 
immunohistochemical analysis showed Matrigel treated with µsp plasma increased the number of 
invading cells, the amount of vascular endothelial growth factor and chondrogenesis while the 
opposite was true for Matrigel treated with nsp plasma. In support of the in vivo Matrigel study, 10 
T1/2 cells cultured in vitro on µsp DBD-treated type I collagen showed increased expression of 
adhesion proteins and activation of survival pathways, which decreased with nsp plasma 
treatments. These results indicate DBD modification of ECM can influence cellular behaviours to 
accelerate or inhibit chondrogenesis and endochondral ossification.
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1. Introduction
Plasma medicine is the clinical application of cold (non-thermal or non-equilibrium) plasma 
to directly treat cells and tissues. Clinical applications of cold plasma currently in 
development include the sterilization of wounds and burns, improved wound healing and 
eradication of cancer cells (Fridman et al., 2006; Brulle et al., 2012; Chernets et al., 2015; 
Daeschlein et al., 2015; Li et al., 2015; Siu et al., 2015; Ulrich et al., 2015). The successful 
use of cold plasma for these applications has led to questions concerning the mechanisms of 
how these treatments affect cell and tissue function. The authors’ laboratory has shown that 
a short cold plasma treatment (10 s) of mesenchymal cells with microsecond pulsed (µsp) 
dielectric barrier discharge (DBD) increases intracellular reactive oxygen species (ROS) and 
ROS-associated signalling to enhance both chondrogenic and osteogenic differentiation 
(Steinbeck et al., 2013). It has also been shown that a single (10 s) plasma treatment of 
murine limb autopods in culture accelerates their development, survival and growth/
elongation (Chernets et al., 2014) by activating ROS-associated signalling pathways. In 
addition, nanosecond pulsed (nsp) DBD for longer periods of time (minutes) effectively 
killed cancer cells and eradicated melanoma tumours through the chemical reactions of ROS 
and reactive nitrogen species (RNS) generated within the tissue (Chernets et al., 2015).
While plasma-generated ROS and RNS are critical components responsible for the 
effectiveness of plasma in wound healing, cancer treatment and bactericidal applications, 
other biophysical stimuli present within the plasma include local and global electric fields, 
shock waves and radiation (Fridman, 2008; Fridman et al., 2008; Kong et al., 2009). The 
amount of each of these biophysical stimuli is largely dependent upon the type of plasma 
and the treatment parameters (Liu et al., 2014). Cold plasma characteristics can be tuned for 
each specific biological application by adjusting the timing, voltage, power, frequency and 
type of electrode. In addition, plasma-generating devices (pulsers) capable of creating faster 
pulse rates (microsecond, nanosecond and picosecond ranges) have been developed. 
Compared with µsp DBD, nsp DBD produces an increased pulse rate with an applied 
voltage approximately 1000 times faster (7.8 kV/ns), creating a more uniform discharge. A 
uniform discharge is thought to decrease the damage to cells and tissues as fewer current 
channels, streamers or filaments (multigenerational accumulation of streamers, like small 
lightning bolts) are formed within the plasma. However, the plasma produced at the higher 
pulse rate also generates greater/cytotoxic concentrations of ROS and RNS (Liu et al., 2014; 
Zhang et al., 2014). To date, there has been a lack of studies characterizing each plasma type 
and condition, which has led to a disconnect in determining how the different plasmas affect 
biological tissues and cellular processes (Jiang et al., 2009; Duval et al., 2013; Alekseev et 
al., 2014; Li et al., 2014). To further confound our understanding, isolated cells treated with 
plasma also tend to react much differently than treated tissues (unpublished data). This is 
most probably because of the differential effects of plasma-generated ROS, RNS and 
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biophysical forces on each cell type within a tissue, the extracellular matrix (ECM) 
molecules interspersed between cells or a combination of effects on cells and ECM.
As a first step in determining the biological difference between µsp and nsp DBD plasmas, 
the commercially available ECM, Matrigel (BD Bioscience, Inc., Franklin Lakes, NJ, USA), 
was treated with each type of DBD as part of a murine ectopic ossification model. In this 
model, it was shown that µsp DBD treatment enhanced cell numbers, cartilage 
differentiation and increased bone formation of the Matrigel ectopic masses. Conversely, 
treatment of the Matrigel with nsp DBD, using the same frequency or power as the µsp 
DBD, had the opposite effect and significantly decreased cell number, slowed cartilage 
differentiation and reduced bone formation. The present study highlights the ability of DBD 
treatments to directly modify ECM and indirectly affect cell behaviour and tissue function. 
In this way, DBD treatment of ECM can be tuned to either negatively or positively influence 
cell–matrix interactions in tissue engineering or clinical applications. Furthermore, 
understanding the effects of plasma on ECM, and not only on cells, is critical for developing 
plasma as a tool for use in any biomedical application.
2. Materials and methods
2.1. Animals
For the experiment, C57BL/6 mice aged 8–12 weeks were obtained from Charles River 
laboratory (Wilmington, MA, USA). The abdominal region was visually divided into four 
quadrants and 250 µl Matrigel was injected subdermally into each quadrant (see section 2.3). 
All animals were euthanized at the 2-week time-point according to National Institutes of 
Health (NIH) guidelines for the care and use of laboratory animals and all animal protocols 
were approved by the Institutional Animal Care and Use Committee (IACUC) at Thomas 
Jefferson University, Philadelphia, PA, USA.
2.2. Cold plasma treatment of Matrigel
Growth Factor Reduced, Phenol Red Free, Corning Matrigel Basement Membrane Matrix 
(BD Bioscience, Inc.) were thawed from −20°C to 4°C and held at 4°C as a liquid. 
Following thawing, 1 ml of liquid Matrigel was dispensed into a six-well plate for treatment 
using a 32 mm plasma electrode (Steinbeck et al., 2013). Plasma treatment of Matrigel was 
performed at 4°C with DBD similar to the procedure described by Fridman et al. (2006), 
where the schematics, voltage and current curves of the power supply (Plasma Power, LLC, 
Philadelphia USA) are detailed. The µsp DBD treatment voltage, frequency, pulse width and 
probe were based on previous publications (Steinbeck et al., 2013; Chernets et al., 2015). 
Briefly, µsp DBD treatment was generated at the voltage of 20 kV (peak to peak), a typical 
rise time of 5 V/ns and a pulse repetition rate of 1 kHz applied through a high-voltage 
electrode covered by 1 mm thick quartz for 1 min. In addition, a nsp-DBD treatment at a 
voltage of 24 kV (peak to peak), with a typical rise time of 7.8 kV/ns and a pulse repetition 
rate of 1 kHz or 0.1 kHz applied through a high-voltage electrode for 1 m. The plastic six-
well plate was placed on a grounded metal plate and the electrode was positioned 2 mm 
above the liquid Matrigel. A comparison of the plasma power measurements for the 1 kHz 
µsp-DBD treatment (1.1 W), 0.1 kHz nsp-DBD treatment (0.8 W) and 1 kHz nsp DBD (9.7 
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W) are shown in Figure 1a and an image of the DBD-treatment setup is shown in Figure 1b. 
Following treatment, Matrigel was promptly removed from the well plate and stored on ice 
before injection into the mice. A small sample of Matrigel was taken for Fourier transform 
infrared spectroscopy (FTIR) analysis and sodium dodecyl sulphate–polyacrylamide gel 
electrophoresis (SDS-PAGE). This treatment protocol was repeated for each of the three 
treatments.
2.3. Mouse ectopic endochondral ossification assay
An experimental model of endochondral ossification was utilized by induction of ectopic 
bone formation, as previously described (Eaton et al., 2014). Briefly, plasma-treated or 
untreated mixtures of Matrigel on ice (BD Bioscience, Inc.) were mixed with 3.5 µg/ml of 
recombinant human bone morphogenetic protein-2 (rhBMP-2; Gene Script Corp., 
Piscataway, NJ, USA) and after mixing aliquots (300 µl) were injected in four subcutaneous 
abdominal sites in 2-month-old CD-1 or C57BL/6 mice following IACUC-approved 
protocols. An untreated BMP-2 positive control, which represented the control (100%) 
response within each mouse, was always included. After 2 weeks the masses were removed 
and microcomputed 1tomography (µCT) analysis was performed using an X-ray tube energy 
of 45 kVp, a current of 177 µA and a 200-ms integration time, producing a spatial resolution 
of 12 µm3 voxel size to measure bone volume over total volume (BV/TV). Each ectopic 
mass was then compared with the positive BMP-2 control and the per cent difference was 
determined. Each treatment was tested independently in at least four individual mice (n = 8 
for 1 kHz microsecond and nanosecond, n = 4 for 0.1 kHz nanosecond). Values collected for 
BV/TV are represented as percentages of control for both variation in the size of the 
Matrigel mass and variation between individual mice.
2.4. Histology and Immunohistochemistry
For histological analyses, Matrigel masses from at least four different mice were collected, 
embedded in paraffin and sectioned at 6 µm thick for each condition (control, µsp DBD, and 
both nsp DBD treatments). Multiple sections from different regions were obtained from each 
Matrigel sample collected. The slides were deparaffinized, rehydrated and stained with 
Alcian Blue (cartilage), trichrome (collagen), Alizarin Red (mineralization) or Vectashield 
Hard Set with 4′,6-diamidino-2-phenylindole (DAPI) (count cells).
Immunohistochemistry detection with 3,3′-diaminobenzidine (DAB) was used to analyse 
vascular endothelial growth factor (VEGF) expression. Tissue slides were deparaffinized, 
rehydrated then subjected to antigen unmasking solution (Vector Labs, Burlingame, CA, 
USA) for 2 × 10 min at 100°C. After washing in phosphate-buffered saline (PBS), all slides 
were incubated with 0.5% Triton in PBS for 10 min at room temperature for 
permeabilization and incubated with a 3% hydrogen peroxide (H2O2) solution in methanol 
for 5 min at room temperature to block endogenous peroxidases. Blocking was performed in 
4% bovine serum albumin (BSA; Equitech-Bio, Kerrville, TX, USA) with 0.1% Tween 20 in 
PBS for 1 h before the primary rabbit anti-VEGF (1:50; Santa Cruz Biotechnology, Inc., 
Dallas, TX, USA) was applied and incubated overnight at 4°C. The secondary horseradish 
peroxidase (HRP)-conjugated rabbit antibody (1:200; Santa Cruz Biotechnology) was 
applied for 1 h at room temperature, before detection with the DAB Peroxidase (HRP) 
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Substrate Kit (Vector Labs). A negative control sample was incubated with no primary 
antibody.
2.5. Fourier transform infrared imaging spectroscopy (FT-IRIS) data acquisition and 
analysis
To assess molecular changes associated with plasma treatment FT-IRIS images were 
obtained from drops of Matrigel deposited on low-e reflective-coated infrared microscope 
slides (MirrIR slides; Kevley Technologies, Chesterland, OH, USA). Matrigel was treated 
with different plasma frequencies before depositing onto low-e reflective-coated infrared 
microscope slides. Data were acquired in the mid-infrared region, 750–2000/cm, at 8/cm 
spectral resolution and 25 µm spatial resolution, with two co-added scans per pixel (15 co-
added scans per pixel for background spectrum) using a Perkin Elmer Spotlight 400 Imaging 
Spectrometer (Shelton, CT, USA). Data were acquired from regions approximately 800 × 
800 µm2 in size, which resulted in approximately 1080 spectra per treatment. Spectral data 
were analysed with ISys 5.0 software (Malvern Instruments, Columbia, MD, USA). 
Absorbances were investigated in the spectral regions where molecular changes are reflected 
in protein structure, primarily the Amide I and Amide II regions, centred at ~1650/cm and 
1550/cm (Barth, 2007). Second derivatives of the spectra were investigated to improve the 
resolution of spectra and identify absorbances that underlie the broad amide bands. The 
intensity of the derivative bands were multiplied by negative one to obtain positive peak 
heights. The FT-IRIS data were also obtained from pure type IV collagen (BD Biosciences–
Discovery Labware, Bedford, MA, USA), the primary protein component of Matrigel, for 
comparison.
2.6. Plasma power measurements for DBD
Discharge energy was measured using P6015A high-voltage probe (75 MHz bandwidth; 
Tektronix, Center Valley, PA, USA) and CM-10-L current monitor (10 ns usable rise time) 
Ion Physics Corporation, Fremont, NH, USA) connected to a 1 GHz DPO-4104B 
oscilloscope (Tektronix, Center Valley, PA, USA). Before taking measurements, signals 
from both probes were synchronized using Tektronix AFG-3252 Arbitrary/Function 
Generator. Energy measurements were performed for the whole duration of voltage 
waveform [~200 ns for nanosecond pulser because of reflections in relatively short (~2 m) 
cable, and ~30 µs for microsecond pulser]. Discharge power was calculated from the energy 
measurements by multiplying the pulse energy by the pulse frequency.
2.7. Hydrogen peroxide, nitric oxide and peroxynitrite production by DBD plasma
Detection of reactive species in gelatin samples was performed similarly as described 
elsewhere (Dobrynin et al., 2012; Park et al., 2013). Hydrogen peroxide was detected by 
measuring fluorescence of 100 µM solution of Amplex UltraRed reagent in PBS (Molecular 
Probes, Eugene, OR, USA) at an excitation frequency of 530 nm and emission at 590 nm, 
with 100 U/µl of H2O2 (MP Biomedicals, Santa Ana, CA, USA) in 10% gelatin prepared in 
PBS. A 100-µl aliquot of reagent solution was added to warm liquid gelatin (1 ml), poured 
into six-well plates and incubated in the dark for 10 min at room temperature until 
solidification. Samples were then treated with DBD at fixed 2 mm distance and fluorescence 
was measured 5 min afterwards using an LS55 (Perkin Elmer) fluorescent spectrometer. 
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Nitric oxide was detected using a similar procedure. For that, 100 µl diaminofluorescein-2 
(DAF-2) reagent (50 µM in dimethylsulphoxide (DMSO) excitation frequency 485 nm, 
emission frequency 538 nm; Cayman Chemical), was added to gelatin before solidification. 
Dichlorodihydrofluorescein diacetate (H2DCFDA, 50 µl in DMSO excitation frequency 495 
nm, emission frequency 518 nm; Molecular Probes) was used to detect peroxynitrite anion 
(ONOO−) in gelatin. In addition, DMSO and horseradish peroxidase (100 U) were used as 
hydroxyl radical (OH) and H2O2 scavengers.
2.8. Collagen treatment and cell culture
A mixture of type I collagen from rat tail (#354236; BD Biosciences, Bedford, MA, USA) 
was prepared at a concentration 0.15 mg/ml in 0.02 N acetic acid. Collagen mixture (1 ml) 
was treated with DBD by the same procedure for Matrigel treatment, as described above. 
Following treatment, 5ml of treated collagen mixture was coated onto culture flasks and 
incubated for 5 min before it was removed from the flasks. The flasks were washed with 
PBS and allowed to air dry before cell culture. CH3/10 T1/2 cells were cultured in collagen 
coated flasks in Dulbecco’s Modified Eagle’s Medium (DMEM; Thermo Fisher, Waltham, 
MA, USA) containing 100 units/ml penicillin, 100 µg/ml streptomycin (Cellgro, Manassas, 
VA, USA), 5% fetal bovine serum (FBS; CellGro) and 5% fetal calf serum (FCS; Gemini, 
West Sacramento, CA, USA) to enhance cell proliferation in a 5%CO2 incubator at 37°C. 
Each flask was coated with collagen treated with a specific DBD application. Cells were 
also cultured in an untreated collagen-coated flask and in an uncoated flask as controls. 
Western analysis was performed after 24 h in culture.
In addition, to visualize the actin cytoskeleton of the cells, the cells were cultured on 
collagen-coated glass cover slips. The collagen was either treated with one of the plasma 
conditions or untreated for control. The coating procedure was similar to the flask coating 
procedure with an incubation time of 5 min with collagen. Alexa Fluor 488® phalloidin 
(#A12379; Life Technologies, Carlsbad, CA, USA) was added to cell culture to visualize 
actin cytoskeleton at 5 µl of 6.6 µM stock/200 µl PBS (as per manufacturer instructions), and 
counterstained with Vectashield Hard Set with DAPI (Vector Labs).
2.9. Western analysis
Cells were lysed in Mammalian Protein Extraction Reagent (MPER; Thermo Fisher), and 
protein concentrations were measured using Bio-Rad Protein Assay (Bio-Rad Laboratories, 
Hercules, CA, USA). Approximately 40 µg of protein was loaded onto each lane of a 
sodium SDS-polyacrylamide gel and, after electrophoresis, the proteins were transferred to a 
polyvinylidene difluoride (PVDF) membrane. The membrane was blocked by incubation in 
Tris-buffered saline (TBS) with 0.05% Tween-20 (Thermo Fisher) and 5% Membrane 
Blocking Agent (GE Healthcare, Amersham, UK) for 1 h while shaking. The membranes 
were then incubated with their respective primary antibodies in TBS with 0.05% Tween-20 
overnight at 4°C. Antibodies used for western blot included rabbit anti-pFAK (#16563), 
mouse anti-FAK (#1688), mouse anti-BCL-2 (#783) and goat anti-β-actin (#81178) (all 
from Santa Cruz Biotechnology) and rabbit anti-AKT (#92725; Cell Signaling Technology, 
Beverly, MA, USA). The primary antibody was removed and the blots were washed three 
times in TBS with 0.05% Tween-20. Their respective horseradish HRP-conjugated 
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secondary antibodies (Santa Cruz) were then applied to the blots which were incubated for 1 
h at room temperature, washed intensively in TBS with 0.05% Tween-20 and then reacted 
with ECL Advanced Detection system (GE Healthcare, Amersham, UK) for 5 min at 25°C. 
Detection of the membranes was done with a FujiFilm Intelligent Darkbox (FujiFilm, 
Tokyo, Japan).
2.10. Imaging and data analysis
Images were acquired with a 12-bit cooled digital camera (Retiga Exi; QImaging, Burnaby, 
BC, Canada) as monochrome with optional LCD colour filter on an Eclipse E800 microscope 
(Nikon, Melville, NY, USA). Histomorphometric analyses were performed using Image Pro 
Plus 7.0 (Media Cybernetics, Silver Spring, MD, USA) to measure a ratio of area positively 
stained to total area. Background intensity was subtracted from each image before 
combining and pseudo-colouring. When the images were enhanced to clearly show 
localization of the protein, all images were enhanced equally. Intensity and localization 
analysis was performed with a custom written module to automate and standardise the 
procedure.
2.11. Statistical analysis
The Kruskal–Wallis test (XLstat; Addinsoft, New York, NY, USA) for one-way analysis of 
variance (ANOVA) in non-parametric samples was used to determine whether there were 
significant differences between the four groups, followed by the student’s t-test (two-tailed 
distribution, two-sample unequal variance) to determine significance (P < 0.05). Statistical 
significance is indicated as * (P < 0.05), ** (P < 0.01), *** (P < 0.001), δ (P < 0.05 for µsp 
DBD vs. nsp DBD 0.1 kHz) and # (P < 0.05 for nsp DBD at 0.1 kHz compared with 1 kHz), 
unless specified otherwise. The data are presented as mean ± SEM.
3. Results
3.1. Treatment of the Matrigel with DBD alters bone formation in the ectopic masses
Microcomputed tomography reconstruction (Figure 1c) and Alizarin Red histological 
staining (Figure 1d) indicate an increased bone and mineral deposition in the µsp DBD-
treated Matrigel masses, whereas a decrease was observed in the nsp DBD-treated masses, 
compared with control. Quantitative µCT analysis of the Matrigel masses confirmed that µsp 
DBD treatment significantly increased bone formation (43% increase in BV/TV; P < 0.05) 
while both nsp DBD treatments significantly decreased bone formation compared with 
control: a 68% decrease in BV/TV at 0.1 kHz (P < 0.01) and 36% decrease in BV/TV at 1 
kHz (P < 0.05) (Figure 1e).
3.2. Treatment of the Matrigel with DBD alters chondrogenesis and cell proliferation/
migration
Histological staining of the Matrigel masses with Alcian Blue highlighted the cartilage-rich 
regions of each treatment (Figure 2a). A more careful examination of the Alcian Blue-
stained regions was performed to determine how treatment of the Matrigel with DBD had 
affected chondrogenesis. Quantification of the Alcian Blue-stained area per total area 
showed significant increases in the per cent cartilage area after 0.1 kHz nsp DBD and 1 kHz 
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nsp DBD, respectively, compared with control (P < 0.05) (Figure 2b). No significant 
difference was observed for µsp DBD. To study the effect of DBD treatment on cell number, 
DAPI fluorescent labelling was used to visualize cell nuclei (Figure 2c). Quantitative 
analysis of the area of DAPI staining per total area revealed that masses where the Matrigel 
was treated with µsp DBD had an increase in DAPI fluorescent area. The nsp DBD 
treatment of the Matrigel at 1 kHz showed no change from control, while nsp DBD 
treatment of the Matrigel at 0.1 kHz showed a decrease in DAPI-stained area (Figure 2d). 
These findings indicate the µsp DBD-treated masses contained a greater percentage of cells 
compared with controls, indicating enhanced cell proliferation or migration into the 
Matrigel, or a combination of both.
3.3. DBD alters the ECM to influence chondrocyte physiology and morphology
Vascular invasion is required for bone to form as the result of endochondral ossification. To 
determine if this process was affected by the DBD treatment of Matrigel 
immunohistochemical staining was performed to show cartilage expression of VEGF. 
Qualitative differences in the distribution and pattern of VEGF staining were observed 
between all treatments (Figure 3a, ×10 magnification). The expression of VEGF stained area 
normalized by total area was measured by automated image analysis. When compared with 
untreated control, the µsp DBD-treated Matrigel showed a significant increase in VEGF 
staining of the Matrigel mass (P < 0.001); in contrast, the nsp DBD-treated Matrigel from 
both frequencies had significantly decreased VEGF expression (P < 0.001) (Figure 3b).
3.4. Fibroblast proliferation induced response to DBD-treated Matrigel
After injection, the Matrigel creates a mild inflammatory response within the host, which 
causes mesenchymal cell migration into the Matrigel. To determine if differences in the 
inflammatory response between the DBD-treated Matrigel was present the thickness of the 
fibrotic ring of cells surrounding each mass (indicating fibroblast proliferation) were 
measured. Formation of a layer of fibroblastic cells is a common foreign body response of 
the host cells indicating an inflammatory response. Images of the perimeter of the 
haematoxylin and eosin (H&E)- and Alcian Blue-stained Matrigel mass from each treatment 
group show a thicker band of fibroblast cells around the nsp DBD- treated masses (Figure 
3c, white brackets). Automated image analysis quantifying the area of the fibroblasts around 
the mass normalized by the total area of the mass revealed that significantly more fibroblasts 
had surrounded the nsp DBD-treated Matrigel, while µsp DBD-treated Matrigel showed no 
differences from control (Figure 3d).
3.5. DBD modifies type IV collagen within the Matrigel
Masson’s trichrome, a histological stain for collagen (blue), was used to stain the cell-free 
areas of Matrigel not occupied by cartilage or bone (Figure 4a, high magnification images). 
The cell-free areas of Matrigel stained blue, owing to the presence of type IV collagen, in 
both control and µsp DBD-treated masses. Interestingly, in both of the nsp DBD-treated 
samples the cell-free collagen-rich regions stained bright red. To determine if the collagen 
had been cleaved or altered, all three samples were analysed by SDS-PAGE and FT-IRIS, 
Electrophoretic analysis of Matrigel showed no alterations in banding patterns of any 
treatment compared with untreated Matrigel, indicating no cleavage of ECM components in 
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the Matrigel (Figure 4b). The second derivative FT-IRIS spectra for pure type IV collagen, 
untreated Matrigel (Control) and Matrigel treated with µsp DBD and nsp DBD were very 
similar (Figure 4c). However, type IV collagen exhibited an amide I absorbance at 1624/cm, 
which was not present in control and treated Matrigel samples. All the DBD-treated 
Matrigel samples showed broadening of the amide I region centred at ~1650/cm, and an 
additional peak absorbance at 1671/cm associated with turn structures in proteins (Barth, 
2007) (Figure 4c).
3.6. DBD-treated collagen modifies cell protein expression
Because Matrigel is a complex mixture of ECM molecules where collagen is only one 
component among other proteins and growth factors, a simpler model was necessary to 
determine how DBD modification of collagen affected cell signalling/behaviour. To 
investigate this, type I collagen from rat tail was treated using the same methods as 
previously used to treat the Matrigel. Changes in the expression of focal adhesion kinase 
(pFAK and FAK), protein kinase B (Akt), B-cell lymphoma 2 (Bcl-2) and cytochrome C 
(CytC) were analysed using western analysis. Cells cultured in flasks that were coated with 
µsp DBD-treated collagen showed increased expression of all proteins, except CytC, which 
was not present. Cells cultured with nsp DBD-treated collagen showed a decrease in the 
expression of all proteins, and the decrease appeared to be dose dependent, with a greater 
decrease in the 1 kHz treatment compared with the 0.1 kHz treatment (Figure 5a). In 
addition, both nsp DBD treatments induced the expression of CytC, an indicator of 
mitochondrial stress. Protein expression of cells cultured in control flasks lacking collagen 
did not differ from cells cultured with untreated collagen, indicating that collagen coating of 
culture flasks does not alter protein expression. Further, fluorescent images of cells stained 
with phalloidin (actin) and DAPI showed decreased spreading in cultures on cover slips 
coated with nsp DBD-treated collagen (Figure 5b), compared with control or µsp DBD-
treated collagen. Finally, to test whether µsp DBD was capable of eliciting a similar 
response, the highest frequency setting available on the µsp DBD device (3.5 kHz, same 
voltage) was used to treat the collagen. At this setting, similar decreases in the expression of 
the four proteins were observed along with cell morphology changes similar to those of cells 
grown on the nsp DBD-treated collagen (see the Supplementary material online, Figure S1).
3.7. Nanosecond DBD generates increased ROS and RNS
To investigate whether differences in ROS and RNS generation by µsp DBD and nsp DBD 
might address differences observed in the reactions with the ECM, the amount of H2O2, 
nitric oxide (NO) and peroxynitrite anion (ONOO−) generated by plasma was measured. A 
10% gelatin solution was used as a substitute for Matrigel and H2O2, NO and ONOO− 
concentrations were determined in a solid gelatin after it was treated (Figure 6a–c). The 
H2O2 production was increased with DBD treatment time for all DBD plasma conditions. 
However, the H2O2 production by µsp-DBD was significantly lower (approximately 1/2 to 
1/3) than either nsp DBD treatments (Figure 4a; P < 0.05) at 30, 60 and 120 s. In addition, 
nsp at 0.1 kHz was significantly lower (P < 0.05) than at 1 kHz at 60 s and 120 s.
Similarly, RNS production in response to both nsp DBD treatments resulted in higher NO 
and ONOO− production (1.5–2 times) compared with µsp DBD at every time-point (Figure 
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4b,c; P < 0.05). After 1 min of treatment, the intensity of fluorescence showed no further 
increase in NO concentration in response to any of the three treatments (Figure 4b). In 
contrast, only the µsp DBD treatment showed saturation of ONOO− after 1 min (~30 a.u.). 
Further, unlike the NO or H2O2 production, the highest ONOO− production was observed 
for the 0.1 kHz nsp DBD treatment rather than the 1 kHz nsp DBD treatment (Figure 6c; P < 
0.05 for µsp DBD vs. nsp DBD at 0.1 kHz and P < 0.05 for nsp DBD at 0.1 kHz compared 
with 1 kHz).
4. Discussion
The present study evaluated the effect of µsp DBD or nsp DBD modification of Matrigel 
ECM on the host cell response in the murine ectopic ossification model. Pretreatment of 
Matrigel with µsp DBD enhanced cell infiltration/numbers, VEGF production, chondrocyte 
differentiation and increased bone formation. These effects were significantly lower after 
nsp DBD treatment at either a comparable power (nsp DBD treatment at pulse repetition rate 
of 0.1 kHz, 0.8 W) or pulse repetition rate (1 kHz, 9.7 W) to µsp DBD treatment (1 kHz, 1.1 
W). The main treatment differences included the increased production by nsp DBD of H2O2, 
NO and ONOO−, the extent of Matrigel collagen modification and the decrease in FAK 
activation. These results demonstrate that plasma changes to the Matrigel ECM could 
effectively enhance or inhibit ECM–cell interactions to alter cellular function and 
endochondral bone formation. Thus, depending on the DBD plasma treatment, the ECM can 
be differentially modified to either enhance or disrupt ECM–cell interactions as required for 
a specific clinical and/or tissue engineering application.
Although the present study controlled for power or frequency to compare µsp DBD with nsp 
DBD, it is challenging to directly compare these discharges as multiple differences exist. It 
was reported that nsp DBD discharges are less filamentary and more uniform than those of 
µsp DBD (Ayan et al., 2008). Additional physical differences include the magnitude of the 
local electric field, thermal differences, the filament-initiated shock wave and the emitted 
radiation (Fridman et al., 2008). Each of these factors has the ability to directly modify ECM 
(Bassett et al., 1982; Brighton et al., 1985; Goodship and Kenwright, 1985; Kenwright and 
Goodship, 1989; Pilla et al., 1990; Joyce et al., 1990; Heckman, 1994; Fredericks et al., 
2000) and therefore are predicted to have different biological outcomes. With the increasing 
number of plasma medicine applications, it is imperative to acquire a better understanding of 
µsp DBD and nsp DBD effects on both ECM and cellular activity. Accordingly, the present 
study selected conditions that evaluated µsp DBD and nsp DBD at either comparable power 
(0.8–1.1 W) or frequency (1 kHz) in an effort to define biological differences and outcomes.
After nsp DBD treatment, a difference in collagen (ECM) staining was observed in the 
Matrigel using trichrome histology. In the staining protocol, an acidic red dye is used that 
binds all basic tissue components; a weak acid wash then removes the red dye from the less 
basic collagen component and an acidic blue dye selectively binds the collagen. Instead of 
staining blue, the collagen appeared red, indicating that nsp DBD changed the basic nature 
of the collagen. A plausible explanation is that the higher production of H2O2, NO and 
ONOO− by nsp DBD modified the amino acid side-chains and thus altered the basic nature 
of collagen. Specifically, the RNS, ONOO−, is known to react with proline/hydroxyproline 
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(prevalent in collagen) and produce the more basic N-nitrosopyrrolidine amino acid, by 
converting the carbonyl to a nitroso group (Ahmad and Ahsan, 2011). Supporting a change 
in amino acid chemistry, as opposed to a structural change or cleavage, analysis of both 
Matrigel and type IV collagen by FTIR and western blot showed no detectable differences 
between µsp DBD and nsp DBD treatment. Together, these results suggest the modification 
of the amino acid side-chains may be responsible for the decreased bone formation after nsp 
DBD treatment.
While it is possible that the lower production of ONOO− by µsp DBD may modify the 
amino acid side-chains to increase bone formation, previous studies have shown that 
biophysical stimuli such as electric fields, ultrasound and mechanical strain can enhance 
endochondral ossification during fracture repair by altering cell interactions with the ECM 
(Bassett et al., 1982; Brighton et al., 1985; Goodship and Kenwright, 1985; Kenwright and 
Goodship, 1989; Pilla et al., 1990; Joyce et al., 1990; Heckman, 1994; Fredericks et al., 
2000). Other studies that specifically investigated the direct effects of biophysical stimuli 
and reactive species on ECM found that structural or conformational alterations exposed 
‘matricryptic’ sites on ECM proteins and carbohydrate groups (Davis et al., 2000). These 
sites are commonly exposed at sites of tissue injury and enhance cell–ECM interactions 
(Davis et al., 2000), leading to the activation of signalling pathways that facilitate tissue 
repair (Reing et al.,). In addition, biophysical stimuli and injury generate biologically active 
ECM peptide fragments, termed ‘matricryptins,’ (Beattie et al., 2008; Reing et al., 2008; 
Tottey et al., 2011). Matricryptins enhance cell migration to the local area and cell 
proliferation, creating favourable conditions for tissue remodelling.
The complexity of Matrigel, a mixture of collagen IV, laminin, entactin, cytokines, 
hormones and growth factors, makes it impossible to determine the plasma modifications to 
each component (Hughes et al., 2010). Thus, in an effort to understand the µsp DBD- and 
nsp DBD-specific effects on a single ECM component, isolated rat tail type I collagen was 
subjected to the same DBD treatments used on the Matrigel. Analysis of protein expression 
by mesenchymal cells grown on the treated collagen showed that µsp DBD treatment 
increased pFAK, FAK and the total cell number compared with nsp DBD treatment. 
Increases in pFAK and FAK indicate enhanced adhesion or cell–ECM interaction through 
integrin binding (Zachary, 1997). In addition, pFAK enhances chondrogenic differentiation, 
which may account for the increases in hypertrophic chondrocytes, VEGF and bone 
formation observed in Matrigel treated with µsp DBD. Furthermore, increases in the anti-
apoptotic proteins Akt and Bcl-2 suggest that the cells grown on µsp DBD-treated collagen 
are less susceptible to apoptosis and cell death. All of these changes support the possibility 
that increases in both the number of cells entering chondrogenesis and the rate of 
chondrogenic differentiation are enhanced in response to the µsp DBD-treated Matrigel/
ECM, resulting in increased bone formation. Notably, when µsp DBD is used at the highest 
setting (3.5 kHz) the expression of pFAK, FAK, Akt and Bcl-2 were decreased compared 
with the untreated collagen, indicating the positive or negative cell–ECM interaction is not 
specifically determined by the DBD pulse rate (see Figure S1, Supplementary material 
online).
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The results of the present study show that ECM molecules can be differentially modified by 
DBD treatment to positively or negatively affect bone formation. The greater amounts of 
ROS and RNS generated by DBD treatment correlated with the modification of collagen and 
a negative effect on chondrogenic differentiation and bone formation. The present work 
highlights the importance of tailoring DBD treatment for each plasma medicine or tissue 
engineering application and provides insight into the potential differences in the biological 
outcomes that result when using µsp DBD vs. nsp DBD.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Dielectric barrier discharge (DBD) treatment of Matrigel effects bone formation. (a) Plasma 
power measurement comparing 1 kHz microsecond pulsed (µsp) DBD treatment (1.1 W), 
0.1 kHz nanosecond pulsed (nsp) DBD treatment (0.8 W) and 1 kHz nsp DBD (9.7 W). (b) 
Apparatus for DBD plasma treatment included an insulated copper electrode with a high 
voltage (HV) connection to the power source (either µs or ns pulser) positioned 2 mm from 
the ice-cooled liquid Matrigel in a six-well plate. (c) Three-dimensional image analysis by 
microcomputed tomography showed visual representation of bone formation in the masses. 
(d) Alizarin Red staining of cross-section of each mass allowed for visualization of calcium 
deposits (red-stained regions of bone formation). (e) Microcomputed tomography analysis of 
bone volume per total volume (BV/TV) represents quantitative analysis of bone formation. 
Treatment with 1 kHz µsp DBD resulted in a 43% increase in BV/TV (P < 0.05), while 0.1 
kHz nsp DBD treatment resulted in a 68% decrease in BV/TV (P < 0.01) and 1 kHz nsp 
DBD treatment resulted in a 36% decrease in BV/TV (P < 0.05). n = 8 for 1 kHz µsp DBD 
and nsp DBD; n = 4 for 0.1 kHz nsp DBD. *P < 0.05, ***P < 0.001. Bar: 1 mm.
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Figure 2. 
Dielectric barrier discharge (DBD) treatment of Matrigel alters chondrogenesis, cell 
migration and proliferation. (a) Alcian Blue staining allowed for specific analysis of 
cartilage-rich regions in sections of masses. (b) Quantitative analysis of stained regions via 
ImagePro Plus software showed an increase in per cent cartilage area in 0.1 kHz and 1 kHz 
nanosecond pulsed (nsp) DBD, respectively (P < 0.05). These results indicate that there are 
greater cartilage-rich regions present in masses treated with nsp DBD. (c) Fluorescent 
analysis with 4′,6-diamidino-2-phenylindole (DAPI) allowed for visualization of cell 
migration and proliferation in sections of masses. (d) Quantitative analysis of DAPI stain via 
ImagePro Plus software showed an increase in the per cent cell area in masses treated with 1 
kHz microsecond pulsed (µsp) DBD (P < 0.05). Masses treated with 0.1 kHz nsp DBD 
showed a decrease in per cent cell area (P < 0.05). n = 4 for all treatments in Alcian Blue 
analysis. n = 6 for DAPI analysis for 1 kHz µsp DBD and nsp DBD, and n = 4 for 0.1 Hz 
nsp DBD. *P < 0.05. Bar: 1 mm.
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Figure 3. 
Dielectric barrier discharge (DBD) treatment effects on chondrocyte physiology and 
morphology. (a) Immunohistochemical staining showed vascular endothelial growth factor 
(VEGF) production (brown staining) and chondrocyte hypertrophy (cells with white spaces) 
was increased with microsecond pulsed (µsp) DBD treatment. (b) Quantitative analysis of 
VEGF confirmed increased VEGF in 1 kHz microsecond pulsed (µsp) DBD-treated masses, 
while nsp-DBD treatment at 0.1 kHz and 1 kHz had decreased VEGF compared with 
control. (c) Haematoxylin and eosin/Alcian Blue stain highlights thickened (red) regions of 
collagen production by fibroblast on the perimeter of Matrigel mass (white brackets) 
representing the foreign body inflammatory response. (d) Quantitative analysis showed an 
increase in inflammatory fibrotic ring surrounding the masses treated with nsp DBD at 0.1 
kHz and 1 kHz, respectively. n = 4; *P < 0.05, ***P < 0.001. Bar: 500 µm.
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Figure 4. 
Modification of collagen by dielectric barrier discharge (DBD) treatment. (A) Trichrome 
staining shows the collagen from the nanosecond pulsed (nsp) DBD-treated Matrigel stains; 
red staining indicates an alteration of collagen compared with the normal blue staining of 
collagen in control and microsecond pulsed (µsp) DBD-treated Matrigel. (b) Sodium 
dodecyl sulphate–polyacrylamide gel electrophoresis performed on control, 1 kHz µsp 
DBD- and 1 kHz nsp DBD-treated Matrigel samples gave in similar band patterns, 
indicating that none of the DBD treatments alter Matrigel by proteolysis. (c) Fourier 
transform infrared imaging spectroscopy analysis of Matrigel samples; second derivative 
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analysis shows the broadening of the amide I contour centred at ~1650/cm and the addition 
of a peak absorbance at 1671/cm (black arrows) in DBD-treated samples, associated with 
protein turn structures. Bar: 500 µm.
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Figure 5. 
Dielectric barrier discharge (DBD) treatment of type I collagen modifies cell protein 
expression. (a) The 24-h culture of C3H/10 T1/2 cells cultured with DBD-treated collagen 
shows altered levels of phosphorylated focal adhesion kinase (pFAK), focal adhesion kinase 
(FAK), protein kinase B (Akt) and B-cell lymphoma 2 (Bcl-2), compared with control. 
Culture with type I collagen treated with microsecond pulsed (µsp) DBD 1 kHz plasma 
increased each protein amount when compared with control. Collagen treated with both 
nanosecond pulsed (nsp) DBD at 0.1 kHz and 1 kHz both resulted in decreased protein 
levels; however 1 kHz nsp DBD treatment showed a greater decrease. Both nsp DBD 
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treatments showed increases in cytochrome C (CytC), while control and µsp DBD 
treatments did not. Untreated type I collagen coated onto cell culture flasks (Coated Control) 
did not induce changes relative to uncoated control flasks. All proteins are normalized to 
actin and represented as up- or down-regulation relative to control. (b) Fluorescent imaging 
of DBD-treated cells after 6 h of culture. Blue indicates 4′,6-diamidino-2-phenylindole 
(DAPI) stain, green indicates actin. Bar: 500 µm.
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Figure 6. 
Dielectric barrier discharge (DBD) treatment produces reactive species in gelatin. (A) 
Hydrogen peroxide (H2O2) production in solidified gelatin (10% gelatin) was measured 
using Amplex UltraRed reagent for H2O2 concentration as a function of time. Nanosecond 
pulsed (nsp) DBD treatments produce 2.5–2.7 times higher amounts of H2O2 compared with 
microsecond pulsed (µsp) DBD treatment at 60 s of treatment. (b) Nitric oxide (NO) 
production in solidified gelatin (10% gelatin) was measured with diaminofluorescein-2 
(DAF-2) reagent for NO concentration over time. The nsp-DBD treatment produces 1.5–2 
times greater concentration of NO compared with µsp DBD treatment. (c) Peroxynitrite 
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(ONOO−) production in solidified gelatin (10% gelatin) was measured with 
dichlorodihydrofluorescein diacetate (H2DCFDA) reagent for ONOO− concentration as a 
function of time. The nsp DBD treatment produces 3–4 times greater concentration of 
ONOO− compared with the µsp DBD treatment. *, P < 0.05, comparing µsp DBD with nsp 
DBD at 1 kHz; δ, P < 0.05; comparing 1 kHz µsp DBD with 0.1 kHz nsp DBD; #, P < 0.05, 
comparing 0.1 kHz nsp DBD with 1 kHz nsp DBD.
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